What are the prospects for coronavirus vaccines and the challenges involved in rolling them out around the world in 2021? The Economist's health policy editor explains what regulatory and logistical obstacles must be overcome as vaccines move from the laboratory to the <a href="https://www.economist.com/britain/2020/10/07/britain-prepares-to-roll-out-a-covid-19-vaccine?utm_campaign=world-ahead&amp;utm_medium=podcast&amp;utm_source=third-party-host&amp;utm_content=show-notes" rel="noopener noreferrer" target="_blank">clinic</a>. And the CEO of Gavi, the vaccine alliance, explores how political and economic factors will govern <a href="https://www.economist.com/graphic-detail/2020/10/08/one-in-three-people-want-preferential-access-to-a-covid-19-vaccine?utm_campaign=world-ahead&amp;utm_medium=podcast&amp;utm_source=third-party-host&amp;utm_content=show-notes" rel="noopener noreferrer" target="_blank">vaccine distribution</a>. Tom Standage hosts.&nbsp;Subscribe to The Economist for full access to print, digital and audio editions: <a href="http://www.economist.com/podcastoffer" rel="noopener noreferrer" target="_blank">www.economist.com/podcastoffer</a>&nbsp; &#10;&nbsp; <hr>See <a style='color: grey; ' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

The World Ahead: A shot in the arm

The Economist